Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. PINK /
  3. REPCF.PINK

RepliCel Life Sciences Inc (REPCF PINK) stock market data APIs

$0.043 0(0%) as of July 26, 2024
Price chart is built with Anychart

RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy to treat tendon injuries, androgenetic alopecia, and skin aging by restoring cellular function to rejuvenate aging or sun damaged skin, regrow hair, and repair tendons. The company's product candidates include RCH-01, a cell therapy for pattern baldness; RCS-01, a cell therapy foraging or sun damaged skin; and RCT-01, a cell therapy for tendon degeneration. It is also developing DermaPrecise, a dermal injection device. The company has a licensing and collaborative agreement with YOFOTO (China) Health Industry Co. Ltd. to develop and commercialize RCS-01, RCT-01, and DermaPrecise. RepliCel Life Sciences Inc. is based in Vancouver, Canada.

RepliCel Life Sciences Inc Financial Data Overview

0.043
0.043
-
0.043
0.043
0.026-0.131
2 795 K
65 002 K
354 K
-0.003
0.824
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'REPCF',
Type: 'Common Stock',
Name: 'RepliCel Life Sciences Inc',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000PMVYS4',
ISIN: 'CA76027P4006',
CUSIP: NULL,
CIK: '1205059',
EmployerIdNumber: '',
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

RepliCel Life Sciences Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 354 K
  • EBITDA -1 048 347
  • Earnings Per Share -0.01
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get RepliCel Life Sciences Inc Earnings via APIs

  • Latest Release 2024-05-30
  • EPS/Forecast NaN

Get RepliCel Life Sciences Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get RepliCel Life Sciences Inc latest news via APIs

TSX Venture Exchange Stock Maintenance Bulletins

VANCOUVER, BC, Jan. 4, 2023 /CNW/ - TSX VENTURE COMPANIES ELEVATION GOLD MINING CORPORATION ("ELVT.WT") BULLETIN TYPE:  Warrant Expiry-Delist BULLETIN DATE:  January 4, 2023 TSX Venture Tier 2 Co...
  • BULLETIN TYPE
  • COMMON SHARE
  • COMMON SHARES
  • COMPANY
  • THE COMPANY
  • THE EXCHANGE
  • TSX VENTURE
  • TSX VENTURE EXCHANGE

RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement

MainPointe Deal Positions RepliCel for entry into the U.S. market and significant milestones in Japan VANCOUVER, BC / ACCESSWIRE / January 25, 2021 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV...
  • COMPANY
  • INJECTOR PRODUCT LINE
  • PARTICIPATION AGREEMENT
  • PRODUCT LINE
  • REGULATORY APPROVAL
  • REPLICEL
  • REPLICEL LIFE SCIENCES INC
  • THE COMPANY
  • TSX VENTURE EXCHANGE
  • TSXV
Do you have any questions?
support@eodhistoricaldata.com